Health

A vaccine focusing on Covid and flu, a brand new venture of the Pfizer-BioNTech alliance

A vaccine focusing on Covid and flu, a brand new venture of the Pfizer-BioNTech alliance

The American pharmaceutical large Pfizer and its German companion BioNTech introduced on Thursday the launch of the primary part of a trial of a candidate vaccine primarily based on messenger RNA combining the safety…

The American pharmaceutical large Pfizer and its German companion BioNTech announce the launch of the primary part of a trial of a vaccine candidate primarily based on messenger RNA combining safety in opposition to influenza and Covid-19 (All rights reserved. © (2022 ) Agence France-Presse – THOMAS KIENZLE)

The American pharmaceutical large Pfizer and its German companion BioNTech introduced on Thursday the launch of the primary part of a trial of a candidate vaccine primarily based on messenger RNA combining safety in opposition to influenza and Covid-19.

The 2 laboratories have already developed one of many best-selling Covid vaccines on this planet.

A mixture vaccine from mRNA know-how “may simplify vaccination practices in opposition to these two respiratory pathogens, doubtlessly main to raised vaccination protection for each ailments,” stated Annaliesa Anderson, chief scientific officer at Pfizer, in an announcement. communicated.

Pfizer and BioNTech be part of different laboratories that are additionally making an attempt to develop a mixed vaccine: the American Moderna has began part 1 of a vaccine in opposition to influenza and Covid, he confirmed on Thursday on the sidelines of the announcement of its quarterly outcomes.

In mid-October, the American biotechnology laboratory Novavax introduced the “constructive outcomes of the part 1 and a couple of medical trial” of a vaccine candidate of this sort.

By 2020, BioNTech and Pfizer had been capable of rapidly and efficiently create the world’s first permitted Covid-19 vaccine, which generated billions of {dollars} in income for each corporations.

The corporate from Mainz (West Germany) will probably be in control of testing the security, the immune response and the optimum dose degree of a mixed candidate vaccine, by recruiting 180 wholesome volunteers aged 18 to 64 in the USA. United, based on a press launch. The follow-up interval for every participant will probably be six months.

Messenger RNA is used to command human cells to fabricate proteins current within the virus with a purpose to accustom the immune system to acknowledge and neutralize it.

The testing part will serve to uncover “the potential of mRNA vaccines focusing on multiple pathogen,” Ugur Sahin, CEO and co-founder of BioNTech, stated within the assertion.

jpl/smk/ial/

#vaccine #focusing on #Covid #flu #venture #PfizerBioNTech #alliance

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also
Close
Back to top button